FDA
-
-
-
-
-
-
-
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
-
-
-
-
-
-
-
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
-
-
-
-
-
-
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Cytokinetics to Hold Annual Meeting of Stockholders
-
-
-
-
-
-
-
Cytokinetics reports positive phase 3 trial results for aficamten
-
-
-
-
-
-
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
-
-
-
-
-
-
Cytokinetics to Announce Fourth Quarter Results on February 24, 2026
-
335,176 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


